Visceral obesity is a negative predictor of remission of diabetes 1 year after bariatric surgery (Q44716465)

5 December 2017

Visceral obesity is a negative predictor of remission of diabetes 1 year after bariatric surgery (English)

1 reference

5 December 2017

0 references

3

1 reference

5 December 2017

Mee Kyoung Kim

1

1 reference

5 December 2017

Hong Chan Lee

2

1 reference

5 December 2017

Ki-Hyun Baek

4

1 reference

5 December 2017

Eung Kook Kim

5

1 reference

5 December 2017

Kwang Woo Lee

6

1 reference

5 December 2017

Ki-Ho Song

7

1 reference

5 December 2017

7 July 2011

1 reference

5 December 2017

1 reference

5 December 2017

19

1 reference

5 December 2017

1835-1839

1 reference

5 December 2017

9

1 reference

The Diabetes Surgery Summit consensus conference: recommendations for the evaluation and use of gastrointestinal surgery to treat type 2 diabetes mellitus

5 December 2017

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.205

Patterns of abdominal fat distribution: the Framingham Heart Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.205

Narrative review: effect of bariatric surgery on type 2 diabetes mellitus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.205

Impact of different bariatric surgical procedures on insulin action and beta-cell function in type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.205

Factors associated with percent change in visceral versus subcutaneous abdominal fat during weight loss: findings from a systematic review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.205

The early effects of weight loss surgery on regional adiposity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.205

Short-term dynamics and metabolic impact of abdominal fat depots after bariatric surgery

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.205

Report: Asian Consensus Meeting on Metabolic Surgery. Recommendations for the use of Bariatric and Gastrointestinal Metabolic Surgery for Treatment of Obesity and Type II Diabetes Mellitus in the Asian Population: August 9th and 10th, 2008, Trivandr

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.205

How do we define cure of diabetes?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.205

Is visceral fat responsible for the metabolic abnormalities associated with obesity?: implications of omentectomy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.205

Potential additional effect of omentectomy on metabolic syndrome, acute-phase reactants, and inflammatory mediators in grade III obese patients undergoing laparoscopic Roux-en-Y gastric bypass: a randomized trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.205

Insulin-sensitive obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.205

Effect of Laparoscopic Roux-En Y Gastric Bypass on Type 2 Diabetes Mellitus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.205

Remission of type 2 diabetes after Roux-en-Y gastric bypass is associated with greater weight loss

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.205

Is Roux-en-Y gastric bypass surgery the most effective treatment for type 2 diabetes mellitus in morbidly obese patients?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.205

Minireview: Hormonal and metabolic mechanisms of diabetes remission after gastrointestinal surgery

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.205

Re-emergence of diabetes after gastric bypass in patients with mid- to long-term follow-up

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.205

Bypassing the duodenum does not improve insulin resistance associated with diet-induced obesity in rodents

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.205

Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.205

Bowels control brain: gut hormones and obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.205

Laparoscopic adjustable gastric banding for the treatment of morbid (grade 3) obesity and its metabolic complications: a three-year study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.205

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/OBY.2011.205

1 reference

5 December 2017

1 reference